Local treatment failure after globe-conserving therapy for choroidal melanoma

British Journal of Ophthalmology

Volumn 97, Issue 7, 2013, Pages 804-811

  Chang, Melinda Y ^a   McCannel, Tara A ^a  

^a JULES STEIN EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CESIUM 131; IODINE 125; PALLADIUM 103; RUTHENIUM 106;

BRACHYTHERAPY; CANCER THERAPY; CHOROID MELANOMA; EXTERNAL BEAM RADIOTHERAPY; GAMMA KNIFE RADIOSURGERY; GLOBE CONSERVING THERAPY; HUMAN; PRIORITY JOURNAL; PROTON THERAPY; RECURRENCE RISK; REVIEW; STEREOTACTIC TREATMENT; TRANSPUPILLARY THERMOTHERAPY; TREATMENT FAILURE; TUMOR ABLATION; TUMOR RECURRENCE; TUMOR VOLUME;

CHOROID; CILIARY BODY; NEOPLASIA; PATHOLOGY;

BRACHYTHERAPY; CHOROID NEOPLASMS; HUMANS; HYPERTHERMIA, INDUCED; MELANOMA; NEOPLASM RECURRENCE, LOCAL; OPHTHALMOLOGIC SURGICAL PROCEDURES; RADIOSURGERY; RISK FACTORS; TREATMENT FAILURE;

EID: 84879414611     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjophthalmol-2012-302490     Document Type: Review

References (63)

1. COMS. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: V. Twelve-year mortality rates and prognostic factors: COMS report No. 28. Arch Ophthalmol 2006;124:1684-93.
2. Char DH, Kroll S, Phillips TL. Uveal melanoma. Growth rate and prognosis. Arch Ophthalmol 1997;115:1014-18.
3. Vrabec TR, Augsburger JJ, Gamel JW, et al. Impact of local tumor relapse on patient survival after cobalt 60 plaque radiotherapy. Ophthalmology 1991;98:984-8.
4. Jampol LM, Moy CS, Murray TG, et al. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: IV. Local treatment failure and enucleation in the first 5 years after brachytherapy. COMS report no. 19. Ophthalmology 2002;109:2197-206.
5. Finger PT. Radiation therapy for choroidal melanoma. Surv Ophthalmol 1997;42:215-32.
6. Earle J, Kline RW, Robertson DM. Selection of iodine 125 for the Collaborative Ocular Melanoma Study. Arch Ophthalmol 1987;105:763-4.
7. McCannel TA, Chang MY, Burgess BL. Multi-Year Follow-up of Fine Needle Aspiration Biopsy in Choroidal Melanoma. Ophthalmology 2012;119:606-10.
8. Tabandeh H, Chaudhry NA, Murray TG, et al. Intraoperative echographic localization of iodine-125 episcleral plaque for brachytherapy of choroidal melanoma. Am J Ophthalmol 2000;129:199-204.
9. COMS. Design and methods of a clinical trial for a rare condition: the Collaborative Ocular Melanoma Study. COMS Report No. 3. Control Clin Trials 1993;14:362-91.
10. Wilkinson DA, Kolar M, Fleming PA, et al. Dosimetric comparison of 106Ru and 125I plaques for treatment of shallow (
11. Damato B, Patel I, Campbell IR, et al. Local tumor control after 106Ru brachytherapy of choroidal melanoma. Int J Radiat Oncol Biol Phys 2005;63:385-91.
12. Verschueren KM, Creutzberg CL, Schalij-Delfos NE, et al. Long-term outcomes of eye-conserving treatment with Ruthenium(106) brachytherapy for choroidal melanoma. Radiother Oncol 2010;95:332-8.
13. Gragoudas ES. Proton beam irradiation of uveal melanomas: the first 30 years. The Weisenfeld Lecture. Invest Ophthalmol Vis Sci 2006;47:4666-73.
14. Wilson MW, Hungerford JL. Comparison of episcleral plaque and proton beam radiation therapy for the treatment of choroidal melanoma. Ophthalmology 1999;106:1579-87.
15. Char DH, Quivey JM, Castro JR, et al. Helium ions versus iodine 125 brachytherapy in the management of uveal melanoma. A prospective, randomized, dynamically balanced trial. Ophthalmology 1993;100:1547-54.
16. Puusaari I, Damato B, Kivela T. Transscleral local resection versus iodine brachytherapy for uveal melanomas that are large because of tumour height. Graefes Arch Clin Exp Ophthalmol 2007;245:522-33.
17. Kivela T, Puusaari I, Damato B. Transscleral resection versus iodine brachytherapy for choroidal malignant melanomas 6 millimeters or more in thickness: a matched case-control study. Ophthalmology 2003;110:2235-44.
18. Zaldivar RA, Aaberg TM, Sternberg P Jr, et al. Clinicopathologic findings in choroidal melanomas after failed transpupillary thermotherapy. Am J Ophthalmol 2003;135:657-63.
19. Shields CL, Shields JA, Perez N, et al. Primary transpupillary thermotherapy for small choroidal melanoma in 256 consecutive cases: outcomes and limitations. Ophthalmology 2002;109:225-34.
20. Melia M, Moy CS, Reynolds SM, et al. Quality of life after iodine 125 brachytherapy vs enucleation for choroidal melanoma: 5-year results from the Collaborative Ocular Melanoma Study: COMS QOLS Report No. 3. Arch Ophthalmol 2006;124:226-38.
21. Gunduz K, Shields CL, Shields JA, et al. Radiation complications and tumor control after plaque radiotherapy of choroidal melanoma with macular involvement. Am J Ophthalmol 1999;127:579-89.
22. Prescher G, Bornfeld N, Hirche H, et al. Prognostic implications of monosomy 3 in uveal melanoma. Lancet 1996;347:1222-5.
23. Kilic E, van Gils W, Lodder E, et al. Clinical and cytogenetic analyses in uveal melanoma. Invest Ophthalmol Vis Sci 2006;47:3703-7.
24. Augsburger JJ, Correa ZM, Trichopoulos N. An alternative hypothesis for observed mortality rates due to metastasis after treatment of choroidal melanomas of different sizes. Trans Am Ophthalmol Soc 2007;105:54-9; discussion 9-60.
25. Chang MY KM, Demanes DJ, Leu M, et al. Intraoperative Ultrasonography-Guided Positioning of Iodine-125 Plaque Brachytherapy in the Treatment of Choroidal Melanoma. Ophthalmology 2012;119:1073-7.
26. Scherer RW, Dickersin K, Langenberg P. Full publication of results initially presented in abstracts. A meta-analysis. JAMA 1994;272:158-62.
27. Correa R, Pera J, Gomez J, et al. (125)I episcleral plaque brachytherapy in the treatment of choroidal melanoma: a single-institution experience in Spain. Brachytherapy 2009;8:290-6.
28. Sia S, Harper C, McAllister I, et al. Iodine-I25 episcleral plaque therapy in uveal melanoma. Clin Experiment Ophthalmol 2000;28:409-13.
29. Quivey JM, Char DH, Phillips TL, et al. High intensity 125-iodine (125I) plaque treatment of uveal melanoma. Int J Radiat Oncol Biol Phys 1993;26:613-18.
30. Jensen AW, Petersen IA, Kline RW, et al. Radiation complications and tumor control after 125I plaque brachytherapy for ocular melanoma. Int J Radiat Oncol Biol Phys 2005;63:101-8.
31. Karlovits B, Trombetta MG, Verstraeten T, et al. Local control and visual acuity following treatment of medium-sized ocular melanoma using a contact eye plaque: A single surgeon experience. Brachytherapy 2011;10:228-31.
32. Sobrin L, Schiffman JC, Markoe AM, et al. Outcomes of iodine 125 plaque radiotherapy after initial observation of suspected small choroidal melanomas: a pilot study. Ophthalmology 2005;112:1777-83.
33. Leonard KL, Gagne NL, Mignano JE, et al. A 17-year retrospective study of institutional results for eye plaque brachytherapy of uveal melanoma using (125)I, (103)Pd, and (131)Cs and historical perspective. Brachytherapy 2011;10:331-9.
34. Sagoo MS, Shields CL, Mashayekhi A, et al. Plaque radiotherapy for juxtapapillary choroidal melanoma: tumor control in 650 consecutive cases. Ophthalmology 2011;118:402-7.
35. Rouberol F, Roy P, Kodjikian L, et al. Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years' experience with beta-rays). Am J Ophthalmol 2004;137:893-900.
36. Novak-Andrejcic K, Jancar B, Hawlina M. Echographic follow-up of malignant melanoma of the choroid after brachytherapy with 106Ru. Klin Monbl Augenheilkd 2003;220:853-60.
37. Papageorgiou KI, Cohen VM, Bunce C, et al. Predicting local control of choroidal melanomas following (106)Ru plaque brachytherapy. Br J Ophthalmol 2011;95:166-70.
38. Frenkel S, Hendler K, Pe'er J. Uveal melanoma in Israel in the last two decades: characterization, treatment and prognosis. Isr Med Assoc J 2009;11:280-5.
39. Finger PT, Berson A, Ng T, et al. Palladium-103 plaque radiotherapy for choroidal melanoma: an 11-year study. Int J Radiat Oncol Biol Phys 2002;54:1438-45.
40. Modorati G, Miserocchi E, Galli L, et al. Gamma knife radiosurgery for uveal melanoma: 12 years of experience. Br J Ophthalmol 2009;93:40-4.
41. Zehetmayer M, Kitz K, Menapace R, et al. Local tumor control and morbidity after one to three fractions of stereotactic external beam irradiation for uveal melanoma. Radiother Oncol 2000;55:135-44.
42. Sarici AM, Pazarli H. Gamma-knife-based stereotactic radiosurgery for medium- and large-sized posterior uveal melanoma. Graefes Arch Clin Exp Ophthalmol 2013;251:285-94.
43. Simonova G, Novotny J Jr, Liscak R, et al. Leksell gamma knife treatment of uveal melanoma. J Neurosurg 2002;97:635-9.
44. Dunavoelgyi R, Dieckmann K, Gleiss A, et al. Local tumor control, visual acuity, and survival after hypofractionated stereotactic photon radiotherapy of choroidal melanoma in 212 patients treated between 1997 and 2007. Int J Radiat Oncol Biol Phys 2011;81:199-205.
45. Al-Wassia R, Dal Pra A, Shun K, et al. Stereotactic Fractionated Radiotherapy in the Treatment of Juxtapapillary Choroidal Melanoma: The McGill University Experience. Int J Radiat Oncol Biol Phys 2011;81:e455-62.
46. Gragoudas ES, Lane AM, Munzenrider J, et al. Long-term risk of local failure after proton therapy for choroidal/ciliary body melanoma. Trans Am Ophthalmol Soc 2002;100:43-8; discussion 8-9.
47. Dendale R, Lumbroso-Le Rouic L, Noel G, et al. Proton beam radiotherapy for uveal melanoma: results of Curie Institut-Orsay proton therapy center (ICPO). Int J Radiat Oncol Biol Phys 2006;65:780-7.
48. Mosci C, Mosci S, Barla A, et al. Proton beam radiotherapy of uveal melanoma: Italian patients treated in Nice, France. Eur J Ophthalmol 2009;19:654-60.
49. Damato B, Kacperek A, Chopra M, et al. Proton beam radiotherapy of choroidal melanoma: the Liverpool-Clatterbridge experience. Int J Radiat Oncol Biol Phys 2005;62:1405-11.
50. Egger E, Schalenbourg A, Zografos L, et al. Maximizing local tumor control and survival after proton beam radiotherapy of uveal melanoma. Int J Radiat Oncol Biol Phys 2001;51:138-47.
51. Fuss M, Loredo LN, Blacharski PA, et al. Proton radiation therapy for medium and large choroidal melanoma: preservation of the eye and its functionality. Int J Radiat Oncol Biol Phys 2001;49:1053-9.
52. Char DH, Kroll SM, Castro J. Ten-year follow-up of helium ion therapy for uveal melanoma. Am J Ophthalmol 1998;125:81-9.
53. Garcia-Arumi J, Zapata MA, Balaguer O, et al. Endoresection in high posterior choroidal melanomas: long-term outcome. Br J Ophthalmol 2008;92:1040-5.
54. Kertes PJ, Johnson JC, Peyman GA. Internal resection of posterior uveal melanomas. Br J Ophthalmol 1998;82:1147-53.
55. Karkhaneh R, Chams H, Amoli FA, et al. Long-term surgical outcome of posterior choroidal melanoma treated by endoresection. Retina 2007;27:908-14.
56. Bechrakis NE, Petousis V, Willerding G, et al. Ten-year results of transscleral resection of large uveal melanomas: local tumour control and metastatic rate. Br J Ophthalmol 2010;94:460-6.
57. Damato BE, Paul J, Foulds WS. Risk factors for residual and recurrent uveal melanoma after trans-scleral local resection. Br J Ophthalmol 1996;80:102-8.
58. Aaberg TM Jr, Bergstrom CS, Hickner ZJ, et al. Long-term results of primary transpupillary thermal therapy for the treatment of choroidal malignant melanoma. Br J Ophthalmol 2008;92:741-6.
59. Stoffelns BM. Primary transpupillary thermotherapy (TTT) for malignant choroidal melanoma. Acta Ophthalmol Scand 2002;80:25-31.
60. Godfrey DG, Waldron RG, Capone A Jr. Transpupillary thermotherapy for small choroidal melanoma. Am J Ophthalmol 1999;128:88-93.
61. Harbour JW, Meredith TA, Thompson PA, et al. Transpupillary thermotherapy versus plaque radiotherapy for suspected choroidal melanomas. Ophthalmology 2003;110:2207-14; discussion 15.
62. Parrozzani R, Boccassini B, De Belvis V, Radin PP, Midena E. Long-term outcome of transpupillary thermotherapy as primary treatment of selected choroidal melanoma. Acta Ophthalmol 2009;87:789-92.
63. Spire M, Devouassoux MS, Kodjikian L, et al. Primary transpupillary thermotherapy for 18 small posterior pole uveal melanomas. Am J Ophthalmol 2006;141:840-9.